Baozun Inc. (BZUN)

Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	155	158	165	312	1,006	2,671
Market Cap Growth	12.18%	-4.25%	-46.89%	-69.02%	-62.34%	29.20%
Enterprise Value	171	373	296	439	1,058	2,370
Last Close Price	2.65	2.72	2.74	5.30	13.90	34.35
PE Ratio	-	-	-	-	-	40.94
Forward PE	8.33	15.52	5.49	7.02	30.69	24.48
PS Ratio	0.12	0.12	0.13	0.26	0.68	1.97
PB Ratio	0.29	0.20	0.20	0.38	0.99	2.84
P/TBV Ratio	0.36	0.37	0.34	0.63	1.57	2.95
P/FCF Ratio	-	-	4.14	12.24	-	87.65
P/OCF Ratio	-	11.42	2.62	5.62	-	56.25
PEG Ratio	-	0.50	0.35	0.45	1.96	0.97
EV/Sales Ratio	0.13	0.29	0.24	0.36	0.72	1.75
EV/EBITDA Ratio	29.83	37.52	2249.46	17.90	39.14	23.12
EV/EBIT Ratio	-	-	-	-	-	29.84
EV/FCF Ratio	-	-	7.42	17.23	-	77.78
Debt / Equity Ratio	0.41	0.36	0.38	0.34	0.53	0.37
Debt / EBITDA Ratio	2.62	2.45	5.01	3.58	7.01	2.68
Debt / FCF Ratio	-	-	7.94	10.96	-	11.55
Asset Turnover	0.97	0.91	0.86	0.75	0.82	1.01
Inventory Turnover	4.48	4.56	4.95	4.93	5.66	5.81
Quick Ratio	1.25	1.33	1.47	1.58	1.53	3.46
Current Ratio	1.99	1.93	1.94	2.01	1.93	4.17
Return on Equity (ROE)	-2.52%	-2.38%	-3.86%	-10.04%	-3.26%	9.76%
Return on Assets (ROA)	-1.28%	-1.04%	-1.52%	-0.15%	-0.19%	3.69%
Return on Capital (ROIC)	-1.57%	-1.34%	-1.99%	-0.19%	-0.23%	4.71%
Return on Capital Employed (ROCE)	-	-	-	-	-	6.30%
Earnings Yield	-16.11%	-16.01%	-23.72%	-30.39%	-3.44%	2.44%
FCF Yield	-	-2.67%	24.14%	8.17%	-5.97%	1.14%
Buyback Yield / Dilution	1.20%	-0.63%	2.58%	15.30%	-13.29%	-6.74%

Updated May 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q